Dynamic change of CD8+ T cell: immunotherapy fate tell?

被引:0
|
作者
Brueckl, Wolfgang M. [1 ]
机构
[1] Paracelsus Med Univ, Gen Hosp Nuernberg, Dept Resp Med Allergol & Sleep Med, Nurnberg, Germany
关键词
Immune-checkpoint inhibitor (ICI); CD8 T cell; prognosis; non-small cell lung cancer (NSCLC); immune checkpoint blockade (ICB); PD-1; BLOCKADE; LYMPHOCYTES;
D O I
10.21037/tlcr-23-139
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:944 / 947
页数:4
相关论文
共 50 条
  • [31] Cytotoxic Efficiency of Human CD8+ T Cell Memory Subtypes
    Knoerck, Arne
    Schaefer, Gertrud
    Alansary, Dalia
    Richter, Josephine
    Thurner, Lorenz
    Hoth, Markus
    Schwarz, Eva C.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] Networks of CD8+ T Cell Response Activation in Melanoma and Vitiligo
    Fukuda, Keitaro
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [33] TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
    Khan, Omar
    Giles, Josephine R.
    McDonald, Sierra
    Manne, Sasikanth
    Ngiow, Shin Foong
    Patel, Kunal P.
    Werner, Michael T.
    Huang, Alexander C.
    Alexander, Katherine A.
    Wu, Jennifer E.
    Attanasio, John
    Yan, Patrick
    George, Sangeeth M.
    Bengsch, Bertram
    Staupe, Ryan P.
    Donahue, Greg
    Xu, Wei
    Amaravadi, Ravi K.
    Xu, Xiaowei
    Karakousis, Giorgos C.
    Mitchell, Tara C.
    Schuchter, Lynn M.
    Kaye, Jonathan
    Berger, Shelley L.
    Wherry, E. John
    NATURE, 2019, 571 (7764) : 211 - +
  • [34] CD8+ T-cell differentiation in chronic HCV infection
    Bengsch, Bertram
    Thimme, Robert
    FUTURE VIROLOGY, 2011, 6 (02) : 249 - 258
  • [35] A study of blood CD3+, CD4+, and CD8+ T cell levels and CD4+:CD8+ ratio in vitiligo patients
    Nigam, P. K.
    Patra, P. K.
    Khodiar, P. K.
    Guai, Jyotsna
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2011, 77 (01):
  • [36] Prognostic Significance of CD4+ and CD8+ T Cell Infiltration Within Cancer Cell Nests in Vulvar Squamous Cell Carcinoma
    Sznurkowski, Jacek Jan
    Zawrocki, Anton
    Emerich, Janusz
    Biernat, Wojciech
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (04) : 717 - 721
  • [37] CD8+ T Cell-Associated Gene Signature Correlates With Prognosis Risk and Immunotherapy Response in Patients With Lung Adenocarcinoma
    Zhang, Minghui
    Ma, Jianli
    Guo, Qiuyue
    Ding, Shuang
    Wang, Yan
    Pu, Haihong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [38] PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer
    Dong, Hongmei
    Xie, Chaoyu
    Yao, Zhimeng
    Zhao, Ruijun
    Lin, Yusheng
    Luo, Yichen
    Chen, Shuanglong
    Qin, Yanfang
    Chen, Yexi
    Zhang, Hao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] A robust CD8+ T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
    Feng, Jinteng
    Xu, Longwen
    Zhang, Shirong
    Geng, Luying
    Zhang, Tian
    Yu, Yang
    Yuan, Rui
    He, Yusheng
    Nan, Zhuhui
    Lin, Min
    Guo, Hui
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [40] CD8+ T-cell specificity is compromised at a defined MFICl/CD8 affinity threshold
    Dockree, Tamsin
    Holland, Christopher J.
    Clement, Mathew
    Ladell, Kristin
    McLaren, James E.
    van den Berg, Hugo A.
    Gostick, Emma
    Miners, Kelly L.
    Llewellyn-Lacey, Sian
    Bridgeman, John S.
    Man, Stephen
    Bailey, Mick
    Burrows, Scott R.
    Price, David A.
    Wooldridge, Linda
    IMMUNOLOGY AND CELL BIOLOGY, 2017, 95 (01): : 68 - 76